Canada markets closed

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.9900-0.0200 (-1.00%)
At close: 04:00PM EDT
2.0400 +0.05 (+2.51%)
After hours: 06:19PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.46
52-Week Change 3-14.96%
S&P500 52-Week Change 3-10.33%
52 Week High 32.7000
52 Week Low 31.8500
50-Day Moving Average 32.1454
200-Day Moving Average 32.2399

Share Statistics

Avg Vol (3 month) 332.01k
Avg Vol (10 day) 333.36k
Shares Outstanding 514.41M
Implied Shares Outstanding 6N/A
Float 89.44M
% Held by Insiders 11.02%
% Held by Institutions 145.91%
Shares Short (Mar 14, 2023) 4226.26k
Short Ratio (Mar 14, 2023) 411.47
Short % of Float (Mar 14, 2023) 42.20%
Short % of Shares Outstanding (Mar 14, 2023) 41.57%
Shares Short (prior month Feb 14, 2023) 4248.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 03, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:18
Last Split Date 3Apr 03, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-12.55%
Return on Equity (ttm)-21.41%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-9.93M
Diluted EPS (ttm)-0.6900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)42.45M
Total Cash Per Share (mrq)2.94
Total Debt (mrq)383k
Total Debt/Equity (mrq)0.92
Current Ratio (mrq)37.72
Book Value Per Share (mrq)2.89

Cash Flow Statement

Operating Cash Flow (ttm)-10.91M
Levered Free Cash Flow (ttm)-7.14M